Semnur Pharmaceuticals, Inc. (SMNR)
0.45
0.00 (0.00%)
USD |
OTCM |
Sep 21, 16:00
Semnur Pharmaceuticals Total Long Term Debt (Quarterly) : 20.94M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.94M |
| March 31, 2026 | 16.92M |
| December 31, 2025 | 11.93M |
| September 30, 2025 | 5.335M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 49.43M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Scilex Holding Co. | 101.51M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |
| Johnson & Johnson | 37.34B |